Mapping of Glutamate Metabolism using 1H FID-MRSI after oral Administration of [1- 13 C]Glc at 9.4 T
Preprint
Abstract
Glutamate is the major excitatory transmitter in the brain and malfunction of the related metabolism is associated with various neurological diseases and disorders. The observation of labeling changes in the spectra after the administration of a 13 C labelled tracer is a common tool to gain better insights into the function of the metabolic system. But so far, only a very few studies presenting the labelling effects in more than two voxels to show the spatial dependence of metabolism. In the present work, the labeling effects were measured in a transversal plane in the human brain using ultra-short TE and TR 1H FID-MRSI. The measurement set-up was most simple: The [1- 13 C]Glc was administered orally instead of intravenous and the spectra were measured with a pure 1H technique without the need of a 13 C channel (as Boumezbeur et al. demonstrated in 2004). Thus, metabolic maps and enrichment curves could be obtained for more metabolites and in more voxels than ever before in human brain. Labeling changes could be observed in [4- 13 C]glutamate, [3- 13 C]glutamate+glutamine, [2- 13 C]glutamate+glutamine, [4- 13 C]glutamine, [2,3- 13 C]aspartate and [6- 13 C]N-acetyl aspartate with a high temporal (3.6 min) and spatial resolution (32×32 grid with nominal voxel size of 0.33 μL) in five volunteers.Keywords
All Related Versions
- Published version: NeuroImage, 270, 119940.
This publication has 58 references indexed in Scilit:
- Metabolic Flux and Compartmentation Analysis in the Brain In vivoFrontiers in Endocrinology, 2013
- Region and state specific glutamate downregulation in major depressive disorder: A meta-analysis of 1H-MRS findingsNeuroscience & Biobehavioral Reviews, 2012
- 13C MRS studies of neuroenergetics and neurotransmitter cycling in humansNMR in Biomedicine, 2011
- Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood DisordersBiological Psychiatry, 2010
- Altered Brain Mitochondrial Metabolism in Healthy Aging as Assessed by in vivo Magnetic Resonance SpectroscopyJournal of Cerebral Blood Flow & Metabolism, 2009
- Slice‐selective FID acquisition, localized by outer volume suppression (FIDLOVS) for 1H‐MRSI of the human brain at 7 T with minimal signal lossNMR in Biomedicine, 2009
- Measuring N-acetylaspartate synthesis in vivo using proton magnetic resonance spectroscopyJournal of Neuroscience Methods, 2008
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disordersNature Reviews Drug Discovery, 2008
- Measurements of the anaplerotic rate in the human cerebral cortex using 13C magnetic resonance spectroscopy and [1‐13C] and [2‐13C] glucoseJournal of Neurochemistry, 2006
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993